| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| UNII: | 1LO2LQW7QG |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 2 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL5095359 |
| FDA SRS | 1LO2LQW7QG |
CONTENTS
| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| UNII: | 1LO2LQW7QG |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL5095359 |
| FDA SRS | 1LO2LQW7QG |